Targeted therapies in leukemia
1 – 30 of 30
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signaling
2024) In Cell Reports(
- Contribution to journal › Article
-
Mark
In-depth proteomic analysis and structural modelling of protein-protein interactions identify known and novel molecular binding partners for EMP3 in erythroid cells
(
- Contribution to journal › Published meeting abstract
- 2023
-
Mark
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
(
- Contribution to journal › Article
-
Mark
Skin mesenchymal niches maintain and protect AML-initiating stem cells
(
- Contribution to journal › Article
-
Mark
Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity
(
- Contribution to journal › Article
-
Mark
CRISPR Screens Identify Candidate Therapeutic Targets in Leukemia
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2022
-
Mark
Interleukin 4 promotes phagocytosis of murine leukemia cells counteracted by CD47 upregulation
(
- Contribution to journal › Article
- 2021
-
Mark
Yippee like 4 (Ypel4) is essential for normal mouse red blood cell membrane integrity
(
- Contribution to journal › Article
-
Mark
Sister chromatid cohesion defects are associated with chromosomal copy number heterogeneity in high hyperdiploid childhood acute lymphoblastic leukemia
(
- Contribution to journal › Article
-
Mark
Arrayed molecular barcoding of leukemic stem cells
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Activation of endogenous retroviruses during brain development causes an inflammatory response
(
- Contribution to journal › Article
- 2020
-
Mark
Functional Screens Identify Vulnerabilities in Acute Leukemia
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells
(
- Contribution to journal › Article
-
Mark
CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia
(
- Contribution to journal › Article
-
Mark
Clonal competition within complex evolutionary hierarchies shapes AML over time
(
- Contribution to journal › Article
- 2019
-
Mark
Vi måste ta ställning till den nya gentekniken
2019) In Svenska Dagbladet, Stockholm(
- Contribution to specialist publication or newspaper › Newspaper article
-
Mark
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells
(
- Contribution to journal › Article
-
Mark
FLT3
N676K
drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis
(
- Contribution to journal › Letter
-
Mark
Att inte debattera är inte ett alternativ
2019) In Svenska Dagbladet, Stockholm(
- Contribution to specialist publication or newspaper › Newspaper article
- 2018
-
Mark
Identification and characterization of candidate therapeutic targets in acute myeloid leukemia
2018)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Studies of Ligands and Receptors Regulating Acute Myeloid Leukemia
(
- Thesis › Doctoral thesis (compilation)
-
Mark
De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
(
- Contribution to journal › Article
-
Mark
CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting
(
- Contribution to journal › Article
- 2017
-
Mark
In-depth genetic analysis of sclerosing epithelioid fibrosarcoma reveals recurrent genomic alterations and potential treatment targets
(
- Contribution to journal › Article
- 2016
-
Mark
IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
(
- Contribution to journal › Article
-
Mark
Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML
(
- Contribution to journal › Article
- 2015
-
Mark
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.
(
- Contribution to journal › Article
-
Mark
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
(
- Contribution to journal › Article
- 2014
-
Mark
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia
(
- Contribution to journal › Article
- 2010
-
Mark
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.
(
- Contribution to journal › Article